Targeting blood thrombogenicity precipitates atherothrombotic events in a mouse model of plaque destabilization

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Liu, Xiaoling ^a   Ni, Mei ^a   Ma, Lianyue ^a   Yang, Jianmin ^a   Wang, Lin ^a   Liu, Fangfang ^a   Dong, Mei ^a   Yang, Xiaoyan ^a   Zhang, Mei ^a   Lu, Huixia ^a   Wang, Jingjing ^a   Zhang, Cheng ^a   Jiang, Fan ^a   Zhang, Yun ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; MATRIX METALLOPROTEINASE; PROTHROMBIN;

ADENOVIRIDAE; ANIMAL; APOPTOSIS; ATHEROSCLEROTIC PLAQUE; COMPLICATION; CONSTRICTION, PATHOLOGIC; DEFICIENCY; DISEASE MODEL; GENE EXPRESSION; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGICAL STRESS; THROMBOSIS;

ADENOVIRIDAE; ANIMALS; APOLIPOPROTEINS E; APOPTOSIS; CONSTRICTION, PATHOLOGIC; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENETIC VECTORS; MATRIX METALLOPROTEINASES; MICE; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC; PROTHROMBIN; STRESS, PHYSIOLOGICAL; THROMBOSIS; TRANSDUCTION, GENETIC;

EID: 84929223493     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10225     Document Type: Article

References (27)

1. Virmani R., Kolodgie F. D., Burke A. P., Farb A. & Schwartz S. M. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc. Biol. 20, 1262-1275 (2000).
2. Finn A. V., Nakano M., Narula J., Kolodgie F. D. & Virmani R. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc. Biol. 30, 1282-1292 (2010).
3. Gough P. J., Gomez I. G., Wille P. T. & Raines E. W. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J. Clin. Invest. 116, 59-69 (2006).
4. Hu J. H. et al. Overexpression of urokinase by plaque macrophages causes histological features of plaque rupture and increases vascular matrix metalloproteinase activity in aged apolipoprotein e-null mice. Circulation 121, 1637-1644 (2010).
5. Schwartz S. M., Galis Z. S., Rosenfeld M. E. & Falk E. Plaque rupture in humans and mice. Arterioscler Thromb Vasc. Biol. 27, 705-713 (2007).
6. von der Thusen J. H. et al. Induction of atherosclerotic plaque rupture in apolipoprotein E-/- mice after adenovirus-mediated transfer of p53. Circulation 105, 2064-2070 (2002).
7. Ni M. et al. Atherosclerotic plaque disruption induced by stress and lipopolysaccharide in apolipoprotein E knockout mice. Am. J. Physiol. Heart Circ. Physiol. 296, H1598-H1606 (2009).
8. Chen Y. C. et al. A novel mouse model of atherosclerotic plaque instability for drug testing and mechanistic/therapeutic discoveries using gene and microRNA expression profiling. Circ. Res. 113, 252-265 (2013).
9. Bentzon J. F. & Falk E. Atherosclerotic lesions in mouse and man: is it the same disease? Curr. Opin. Lipidol. 21, 434-440 (2010).
10. Ueda Y. et al. Acute coronary syndrome: insight from angioscopy. Circ. J. 74, 411-417 (2010).
11. Welch C. L. et al. Spontaneous atherothrombosis and medial degradation in Apoe-/-, Npc1-/- mice. Circulation 116, 2444-2452 (2007).
12. Burke A. P. et al. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 103, 934-940 (2001).
13. Schulz C. et al. Effect of chronic treatment with acetylsalicylic acid and clopidogrel on atheroprogression and atherothrombosis in ApoE-deficient mice in vivo. Thromb Haemost 99, 190-195 (2008).
14. Stone G. W. et al. A prospective natural-history study of coronary atherosclerosis. N. Engl. J. Med. 364, 226-235 (2011).
15. Sasaki T. et al. A simple method of plaque rupture induction in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc. Biol. 26, 1304-1309 (2006).
16. Rioufol G. et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 106, 804-808 (2002).
17. Abdullah W. Z., Moufak S. K., Yusof Z., Mohamad M. S. & Kamarul I. M. Shortened activated partial thromboplastin time, a hemostatic marker for hypercoagulable state during acute coronary event. Transl. Res. 155, 315-319 (2010).
18. Hammoudeh A. J. & Alhaddad I. A. Triggers and the onset of acute myocardial infarction. Cardiol. Rev. 17, 270-274 (2009).
19. Borissoff J. I., Spronk H. M., Heeneman S. & ten Cate H. Is thrombin a key player in the 'coagulation-atherogenesis' maze? Cardiovasc Res. 82, 392-403 (2009).
20. Galis Z. S., Kranzhofer R., Fenton J. W. & Libby P. Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells. Arterioscler Thromb Vasc. Biol. 17, 483-489 (1997).
21. Martorell L. et al. Thrombin and protease-activated receptors (PARs) in atherothrombosis. Thromb Haemost 99, 305-315 (2008).
22. Manoharan G. et al. Severity of coronary arterial stenoses responsible for acute coronary syndromes. Am. J. Cardiol. 103, 1183-1188 (2009).
23. von der Thusen J. H., van Berkel T. J. & Biessen E. A. Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Circulation 103, 1164-1170 (2001).
24. Bernberg E., Andersson I. J., Tidstrand S., Johansson M. E. & Bergstrom G. Repeated exposure to stressors do not accelerate atherosclerosis in ApoE-/- mice. Atherosclerosis 204, 90-5 (2009).
25. Falk E., Schwartz S. M., Galis Z. S., Rosenfeld M. E. Putative murine models of plaque rupture. Arterioscler Thromb Vasc. Biol. 27, 969-972 (2007).
26. Viles-Gonzalez J. F., Fuster V. & Badimon J. J. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur. Heart J. 25, 1197-1207 (2004).
27. Levy A. P. & Moreno P. R. Intraplaque hemorrhage. Curr. Mol. Med. 6, 479-488 (2006).